1Franeeseo S, Pedro A, Chi HL, et al. Sirolimus - eluting stentimplantation in ST- segment elevation myocardial infarction [ J ]. Circulation, 2003,108 : 1927.
2Lemos PA,Saia F,Hofma SH,et al. Short and long term clinical benefit of sirolimus - eluting stents compared to conventional bare stents for patients with acute myocardial infarction [ J ]. J Am Coll Cardiol, 2004, 43:704.
3Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus - eluting stentsvsabeiximab and bare - metal stent for acute myocardial infarction : a randomized trial[ J]. JAMA ,2005, 293 ( 17 ) : 2109.
6Steven O, Andrew R. The development of rapamycin and its application to stent restenosis[J]. Circulation,2001,104: 852-855.
7Morice MC, Serruys PW, Sousa JE, et al, A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascu-larization.The REVEL trial[J]. N Engl J Med, 2002, 346: 1773-1780.
8Patrick W, Muzaffer D, Kengo T, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL trial[J].Circulation, 2002,106: 798-803.
9Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stent [ J ]. Circulation,2001,104:2007-2011.
10Sousa JE,Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stent, :part Ⅰ [J]. Circulation, 2003, 107 : 2274-2279.
